MERCK & CO., INC.

(MRK)
  Bericht
Verzögert Nyse  -  17/05 22:03:22
93.00 USD   +0.74%
17.05.Calliditas Therapeutics beginnt mit der Rekrutierung für Studie zu Kopf- und Halskrebs im mittleren Stadium
MT
17.05.MERCK & CO., INC. : Berenberg Bank klebt neutral
MM
16.05.Neoleukin Therapeutics behandelt ersten Tumorpatienten in Studie zur Bewertung von NL-201 mit Keytruda
MT
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über MERCK & CO., INC.
17.05.Calliditas Therapeutics Starts Enrollment of Mid-Stage Head and Neck Cancer Study
16.05.Neoleukin Therapeutics Treats First Tumor Patient in Trial Evaluating NL-201 With Keytr..
16.05.Athenex, Merck Collaborate to Study Oraxol Plus Keytruda in Non-Small Cell Lung Cancer
16.05.Rising Cyber Attacks Could Make Insurance Unaffordable
13.05.Tesla, Occidental rise; New Relic, Merck fall
12.05.Thinking about trading options or stock in Hess, Electronic Arts, Merck, Microsoft, or ..
11.05.TRANSCRIPT : Merck & Co., Inc. Presents at Bank of America 2022 Healthcare Conference, May..
11.05.L'efficacité du médicament anticancéreux de Roche remise en question
10.05.SECTOR UPDATE : Health Care Stocks Still Edging Higher This Afternoon
10.05.Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medic..
10.05.Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medic..
05.05.MERCK & CO., INC. Management's Discussion and Analysis of Financial Condition and Resu..
05.05.Nabriva Therapeutics Signs Extended Deal With Merck to Promote, Distribute Sivextro Thr..
05.05.Nabriva Extends Exclusive Agreement to Promote and Distribute Sivextro® (Tedizolid Phos..
04.05.Amphista Therapeutics Announces Strategic Collaboration with Merck Healthcare, Division..
04.05.Merck to Participate in Bank of America Securities 2022 Healthcare Conference
02.05.Merck - European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy..
02.05.Merck - European Commission Approves Merck's KEYTRUDA (pembrolizumab) for Patients With..
02.05.Thinking about trading options or stock in Merck, Tesla, Netflix, Advanced Micro Device..
02.05.UNIVERSITY OF CHICAGO : A new technique to delete single atoms can speed up molecule desig..
02.05.Imugene Limited Announces Termination of Supply Agreement
29.04.Merck & Co. Receives EU Approval for Cancer Immunotherapy Keytruda
29.04.Merck Says EC Approves Keytruda Regimen to Treat Advanced Cervical Cancer
29.04.MERCK : l'UE approuve Keytruda dans de nouvelles indications
29.04.Ionova Life Science Co., Ltd. Announces Clinical Trial Collaboration with Merck & Co., ..
29.04.European Commission Approves Merck's KEYTRUDA® (pembrolizumab) for Patients With Micros..
29.04.European Commission Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With ..
29.04.Merck Gets Expanded Europe OK for Keytruda in Cervical Cancer
29.04.AstraZeneca Moves to Secure Long-Term Growth With New R&D Hub Amid Expected Drop in COV..
28.04.Merck dopé par la vente pour 3,2 milliards USD de sa nouvelle pilule anti-Covid
28.04.COVID-19 treatment, Keytruda boost drugmaker Merck in Q1
28.04.Merck & Co. Lifts 2022 EPS, Sales Guidance
28.04.La píldora para el Covid-19 de Merck supera los 3.200 millones de dólares en ventas tri..
28.04.MERCK : 1Q22 Merck Earnings Presentation
28.04.TRANSCRIPT : Merck & Co., Inc., Q1 2022 Earnings Call, Apr 28, 2022
28.04.MERCK : BPA de 1,70 $ au premier trimestre 2022
28.04.MERCK : Announces First-Quarter 2022 Financial Results - Form 8-K
28.04.Merck Posts Higher Q1 Adjusted Earnings, Sales; Raises Full-Year 2022 Outlook
28.04.MERCK : Q1 Earnings Snapshot
28.04.GUIDANCE : (MRK) MERCK & CO. Sees Fiscal Year 2022 EPS Range $7.24 - $7.36
28.04.GUIDANCE : (MRK) MERCK & CO. Expects Fiscal Year 2022 Revenue Range $56.9B - $58.1B
28.04.Earnings Flash (MRK) MERCK & CO. Reports Q1 Revenue $15.9B
28.04.Earnings Flash (MRK) MERCK & CO. Reports Q1 EPS $2.14
28.04.Merck Announces First-Quarter 2022 Financial Results
28.04.Merck & Co., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
28.04.Merck & Co., Inc. Provides Earnings Guidance for the Year 2022
28.04.BOLSA DE MADRID : La venganza de Meta
28.04.La vengeance pour Meta, la dépréciation pour TotalEnergies
28.04.EN DIRECT DES MARCHES : Capgemini, TotalEnergies, Thales, Soitec, Albioma, Nokia, Meta, Pa..
26.04.Merck Receives Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) Plus Chemotherapy ..
25.04.MERCK : avis favorable du CHMP pour Keytruda
25.04.Merck Receives EU Recommendation For Triple-negative Breast Cancer Treatment Approval
25.04.Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy..
25.04.Merck Receives Positive EU Chmp Opinion for Keytruda(R) (Pembrolizumab) Plus Chemothera..
25.04.Merck Gets CHMP Backing for Expanded Keytruda Use in Breast Cancer
22.04.Pfizer Wins WHO Endorsement For Antiviral Pill In High-Risk COVID-19 Patients
21.04.PLEADING AND PREEMPTION : Immunization Against Vaccine Products Liability Claims
21.04.MERCK : Asset Acquisition - Form 8-K
21.04.MERCK & CO., INC. : Results of Operations and Financial Condition, Other Events, Financial..
20.04.MERCK : nouveau directeur du pôle Human Health International
20.04.Merck Announces That Joseph Romanelli Will Lead Merck Human Health International, Effec..
18.04.Health Canada Approves KEYTRUDA® (pembrolizumab) for the treatment of adult patients wi..
18.04.Merck Receives Approval from Health Canada for KEYTRUDA
14.04.MERCK : décision de la FDA pour le vaccin V116
14.04.Merck Receives FDA Breakthrough Therapy Designation for Pneumococcal Conjugate Vaccine
14.04.Merck Announces U.S. FDA has Granted Breakthrough Therapy Designation for V116, the Com..
14.04.Merck Gets FDA Breakthrough Therapy Designation for V116 Vaccine
11.04.Merck Says Health Canada Expands HPV Vaccine Gardasil 9's Marketing Authorization
11.04.Health Canada Approves GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) ..
11.04.Health Canada Approves Merck & Co., Inc.'s Gardasil®9 for the Prevention of Oropharynge..
11.04.Merck Gets Approval to Expand Gardasil Indication in Canada
08.04.Compañías que se deben tener muy en cuenta por técnico este viernes en Wall Street
08.04.Merck to Hold First-Quarter 2022 Sales and Earnings Conference Call April 28
06.04.Expansion of Elkton, Virginia Manufacturing Facility to Further Increase MSD's HPV Vacc..
06.04.Expansion of Elkton, Virginia Manufacturing Facility to Further Increase MSD's HPV Vacc..
1  2  3  4  5  6  7  8  9  10Weiter
Offizielle Publikationen
Anstehende Termine für MERCK & CO., INC.